LRPA
RKDA icon

L. Roy Papp & Associates’s Arcadia Biosciences RKDA Stock Holding History

L. Roy Papp & Associates’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-464
Closed -$445K – 161
2018
Q1 		$445K Buy
+464
New +$209K 0.09% 121
2017
Q3 		– Sell
-925
Closed -$333K – 135
2017
Q2 		$333K Buy
925
+402
+77% +$224K 0.07% 122
2017
Q1 		$285K Buy
523
+62
+13% +$44.5K 0.06% 116
2016
Q4 		$339K Hold
461
– – 0.08% 122
2016
Q3 		$718K Sell
461
-9
-2% -$15.9K 0.17% 94
2016
Q2 		$973K Buy
470
+143
+44% +$239K 0.23% 80
2016
Q1 		$726K Buy
+327
New +$695K 0.17% 92

Other funds holding RKDA

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

L. Roy Papp & Associates's RKDA Position: Q2 2018 in Review

L. Roy Papp & Associates sold out of Arcadia Biosciences (RKDA) in Q2 2018, closing a stake of 464 shares — an estimated $445K sold.

L. Roy Papp & Associates first reported a position in RKDA in Q1 2016 and held it in 7 quarters. The position peaked at $973K in Q2 2016. 13 funds tracked by Wall St. Rank hold RKDA as of Q2 2018.

  • L. Roy Papp & Associates reported no remaining Arcadia Biosciences position as of Q2 2018 after selling out during the quarter.
  • L. Roy Papp & Associates sold 464 Arcadia Biosciences shares in Q2 2018, an estimated $445K.
  • L. Roy Papp & Associates first reported a position in Arcadia Biosciences in Q1 2016 and held it in 7 quarters.
  • L. Roy Papp & Associates's Arcadia Biosciences position peaked at $973K in Q2 2016.
  • 13 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q2 2018.

Based on L. Roy Papp & Associates's 13F filing for Q2 2018, filed 9 Aug 2018.